Inthera Bioscience
Pre-clinicalFocuses on developing small molecule therapies for oncology targets.
Founded
2017
Focus
Small Molecules
About
Focuses on developing small molecule therapies for oncology targets.
Funding History
2Total raised: $75M
Series B$50MVersant VenturesJun 15, 2022
Series A$25MVersant VenturesOct 15, 2020
Company Info
TypePrivate
Founded2017
LocationZurich, Switzerland
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
3Brain
Pre-clinical · Zug
Baxiva
Pre-clinical · Zug
AC Bioscience
Pre-clinical · Lausanne
Abrinca Genomics
Pre-clinical · Zurich
AdipoGen
Pre-clinical · Liestal
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile